Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Expert Rev Clin Pharmacol. 2015 Oct 14;9(1):59–68. doi: 10.1586/17512433.2016.1096772

Table 1.

Metabolic complications of lipodystrophy

Glucose metabolism
Insulin resistance
Diabetes
Acanthosisnigricans
Lipid metabolism
High triglycerides
  Eruptive xanthomata
  Pancreatitis
Nonalcoholic fatty liver disease (NAFLD)
  Steatosis→
  Nonalcoholic steatohepatitis (NASH)→
  Cirrhosis
Reproductive
Polycystic ovarian syndrome (PCOS)
Abnormal gonadotropin secretion